International Variation in Clozapine Hematologic Monitoring-A Call for Action

JAMA Psychiatry. 2023 Jun 1;80(6):535-536. doi: 10.1001/jamapsychiatry.2023.0376.

Ebenezer Oloyede^{1

2}, David Taylor^{3

4}, James MacCabe^{1

5}

¹ Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, United Kingdom.
² Department of Psychiatry, Warneford Hospital, University of Oxford, Oxford, United Kingdom.
³ Institute of Pharmaceutical Science, King's College London, London, United Kingdom.
⁴ Pharmacy Department, South London and Maudsley NHS Foundation Trust, London, United Kingdom.
⁵ National Psychosis Service, South London and Maudsley NHS Foundation Trust, London, United Kingdom.

No abstract available

Plain language summary

The Viewpoint describes variations in stringency of clozapine hematologic monitoring among countries and suggests hematologic monitoring approaches.